Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Jorge Cortes is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
THERAPY OF CML
Cortes, J. (PI), Kurzrock, R. (PI), Ming-Sheng, L. (PI), Reading, C. (PI), Emerson, S. (PI), Liang, J. (PI), Deisseroth, A. (PI), Feinberg, A. (PI), Siciliano, M. (PI), Kantarjian, H. (PI), Talpaz, M. (PI), Andreeff, M. (PI), Kornblau, S. (PI), Thall, P. (PI), Issa, J. P. (PI), Estrov, Z. (PI), Arlinghaus, R. B. (PI), Deininger, M. (PI), Champlin, R. (PI), Shpall, E. (PI), Austin, D. (PI), Claxton, D. (PI), Belmont, J. (PI), Reisner, Y. (PI) & Issa, K.-P. (PI)
Project: Research project
-
Improving the Outcome of Patients with Chronic Myeloid Leukemia Through Medi
Cortes, J. (PI)
7/1/10 → 6/30/15
Project: Research project
-
The Therapy of CML
Andreeff, M. W. (CoPI), Arlinghaus, R. B. (CoPI), Austin, D. J. (CoPI), Belmont, J. (CoPI), Champlin, R. E. (CoPI), Claxton, D. (CoPI), Deisseroth, A. B. (CoPI), Emerson, S. G. (CoPI), Estrov, Z. (CoPI), Feinberg, A. P. (CoPI), Kantarjian, H. (CoPI), Kornblau, S. (CoPI), Kurzrock, R. (CoPI), LEE, M.-S. (CoPI), Liang, J. C. (CoPI), Reading, C. L. (CoPI), Reisner, Y. (CoPI), Siciliano, M. J. (CoPI), Talpaz, M. (CoPI), Thall, P. F. (CoPI), Champlin, R. R. E. (PI), Cortes, J. (CoPI), Deininger, M. W. (CoPI), Issa, J.-P. J. (CoPI), Kornblau, S. M. (CoPI), Shpall, E. J. (CoPI) & Champlin, R. (CoPI)
12/1/89 → 6/30/16
Project: Research project
-
How can we chop CML with an ASXL1?
Cortes, J., Dec 4 2025, In: Blood. 146, 23, p. 2741-2742 2 p.Research output: Contribution to journal › Editorial › peer-review
Open Access -
Olutasidenib for mutated IDH1 acute myeloid leukemia: final five-year results from the phase 2 pivotal cohort
Cortes, J., Curti, A., Fenaux, P., Jonas, B. A., Krauter, J., Montesinos, P., Récher, C., Taussig, D. C., Wang, E. S., Watts, J., Wei, A., Yee, K. W. L., Tian, H., Sheppard, A., Marzac, C. & de Botton, S., Dec 2025, In: Journal of Hematology and Oncology. 18, 1, 102.Research output: Contribution to journal › Article › peer-review
Open Access -
Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial
the Olutasidenib Combination Therapy Study Group, Dec 2025, In: Journal of Hematology and Oncology. 18, 1, 7.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Outcomes for Primary Central Nervous System Lymphoma from a Single Institution
Dontu, S., Boccucci, J., Chahin, M., Keruakous, A., Jillella, A., Cortes, J., Kota, V., Bryan, L. & Chauhan, A., Dec 2025, In: Hematology Reports. 17, 6, 55.Research output: Contribution to journal › Article › peer-review
Open Access -
Estimating the burden of chronic stress through allostatic load in patients with chronic myeloid leukemia
Miranda-Galvis, M., Tjioe, K. C., Sharara, M., Maloney, M., Keruakous, A. R., Jillella, A., Kota, V., Guha, A. & Cortes, J. E., Nov 2025, In: Leukemia. 39, 11, p. 2735-2744 10 p.Research output: Contribution to journal › Article › peer-review